Cargando…

Chemoembolization for hepatocellular carcinoma fed by right internal thoracic artery

The purpose of the study was to evaluate the value of transarterial chemoembolization (TACE) via right internal thoracic artery (RITA) for patients with unresectable hepatocellular carcinoma (HCC). From January 2000 to June 2016, a retrospective study was conducted of all patients with unresectable...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Tao, Jia, Zhongzhi, Huang, Yuanquan, Li, Shaoqin, Jiang, Guomin, Cheng, Lihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690792/ https://www.ncbi.nlm.nih.gov/pubmed/29137099 http://dx.doi.org/10.1097/MD.0000000000008634

Ejemplares similares

Transarterial embolization/chemoembolization therapy for hepatocellular carcinoma fed by adrenal artery: Preliminary results
por: Hu, Shibing, et al.
Publicado: (2016)

Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection
por: Jing, Chu-Yu, et al.
Publicado: (2017)

Ruptured Hepatic Carcinoma After Transcatheter Arterial Chemoembolization()
por: Jia, Zhongzhi, et al.
Publicado: (2013)

Efficacy and Safety of Intensity-Modulated Radiotherapy Following Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma
por: Zhang, Tao, et al.
Publicado: (2016)

Prognostic significance of serum procalcitonin in patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization: A retrospective analysis of 509 cases
por: Shen, Hujia, et al.
Publicado: (2017)

Transcatheter Arterial Chemoembolization With Gelatin Sponge Microparticles Treated for BCLC Stage B Hepatocellular Carcinoma: A Single Center Retrospective Study
por: Kamran, Asad Ullah, et al.
Publicado: (2015)

350–560 μm gelatin sponge particles combined with transcatheter arterial chemoembolization for the treatment of elderly hepatocellular carcinoma: The safety and efficacy
por: Zhao, Guang Sheng, et al.
Publicado: (2017)

Determination of risk factors for fever after transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma
por: Li, Jinpeng, et al.
Publicado: (2021)

Pancreas lipiodol embolism induced acute necrotizing pancreatitis following transcatheter arterial chemoembolization for hepatocellular carcinoma: A case report and literature review
por: Tan, Youwen, et al.
Publicado: (2019)

Postsurgical treatment with adjuvant transarterial chemoembolization in patients with hepatitis B-related hepatocellular carcinoma: A strobe-compliant article
por: Hu, Hao, et al.
Publicado: (2016)

Efficacy and safety of transarterial chemoembolization plus lenvatinib in the treatment of advanced hepatocellular carcinoma: A meta-analysis
por: Li, Dailong, et al.
Publicado: (2023)

Drug-eluting beads versus conventional transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis
por: Wang, Zi-Yu, et al.
Publicado: (2023)

Combination of transcatheter arterial chemoembolization and interrupted dosing sorafenib improves patient survival in early–intermediate stage hepatocellular carcinoma: A post hoc analysis of the START trial
por: Lee, Teng-Yu, et al.
Publicado: (2017)

Transarterial chemoembolization plus sorafenib versus sorafenib for intermediate–advanced hepatocellular carcinoma: A meta-analysis comparing clinical outcomes
por: Xie, Yong, et al.
Publicado: (2021)

Repeated Radiofrequency Ablation Combined With Ablated Lesion Elimination and Transarterial Chemoembolization Improves the Outcome of Solitary Huge Hepatocellular Carcinomas 10 cm or Larger
por: Ke, Shan, et al.
Publicado: (2016)

Effects of transarterial chemoembolization combined with antiviral therapy on HBV reactivation and liver function in HBV-related hepatocellular carcinoma patients with HBV-DNA negative
por: Wang, Kai, et al.
Publicado: (2018)

The incidence and outcome of major complication following conventional TAE/TACE for hepatocellular carcinoma
por: Tu, Jianfei, et al.
Publicado: (2016)

Association of TNIP1 polymorphisms with hepatocellular carcinoma in a Northwest Chinese Han population
por: Shi, Yuting, et al.
Publicado: (2021)

Thoracic vertebral metastasis from progressive hepatocellular carcinoma following liver transplantation combined with resection of mesenteric and colonic metastases: A case report
por: Hu, Jingen, et al.
Publicado: (2020)

Serum microRNA panel for early diagnosis of the onset of hepatocellular carcinoma
por: Zhang, Ying, et al.
Publicado: (2017)

Bulbar Paralysis and Facial Paralysis due to Metastatic Hepatocellular Carcinoma: A Case Report and Literature Review
por: Liu, Min, et al.
Publicado: (2016)

Intelectin-1 is a novel prognostic biomarker for hepatocellular carcinoma
por: Li, Jiang, et al.
Publicado: (2023)

Efficacy of treatment regimens for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials
por: Chen, Qi-Feng, et al.
Publicado: (2019)

Postoperative radiotherapy for the young–old patients with thoracic esophageal squamous cell carcinoma: A 2-center experience
por: Ding, Wei, et al.
Publicado: (2020)

Higher neutrophil-lymphocyte ratio is associated with better prognosis of hepatocellular carcinoma
por: Li, Sheng-chao, et al.
Publicado: (2020)

Association Between Expression of Cancer Stem Cell Markers and Poor Differentiation of Hepatocellular Carcinoma: A Meta-Analysis (PRISMA)
por: Liu, Rui, et al.
Publicado: (2015)

Identification of cancer-associated fibroblasts signature for predicting the prognosis and immunotherapy response in hepatocellular carcinoma
por: Ye, Jianzhong, et al.
Publicado: (2023)

Prognostic value and potential molecular mechanism of ITGB superfamily members in hepatocellular carcinoma
por: Xie, Haixiang, et al.
Publicado: (2023)

A rare case of Merkel cell carcinoma presenting as a giant intra-thoracic mass: A case report and review of the literature
por: Kong, Feng-Wei, et al.
Publicado: (2017)

Statin-Based Palliative Therapy for Hepatocellular Carcinoma
por: Shao, Joni Yu-Hsuan, et al.
Publicado: (2015)

Transarterial embolization/chemoembolization therapy for hepatocellular carcinoma fed by adrenal artery: Preliminary results: Erratum
Publicado: (2017)

Recurrence of Hepatocellular Carcinoma With Epithelial–Mesenchymal Transition After Spontaneous Regression: A Case Report
por: Yang, Shi-zhong, et al.
Publicado: (2015)

Research trends for papillary thyroid carcinoma from 2010 to 2019: A systematic review and bibliometrics analysis
por: Huang, Fengyan, et al.
Publicado: (2021)

Significant Association Between Adiponutrin and Hepatocellular Carcinoma Risk
por: Li, Hong-Guang, et al.
Publicado: (2015)

High-dose radiation therapy alone by moderate hypofractionation for patients with thoracic esophageal squamous cell carcinoma
por: Oh, Dongryul, et al.
Publicado: (2016)

Overexpression of CD39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection
por: Cai, Xiao-Yan, et al.
Publicado: (2016)

Impact of tumor size on outcome after stereotactic body radiation therapy for inoperable hepatocellular carcinoma
por: Kuo, Hsing-Tao, et al.
Publicado: (2017)

Prognostic role of urokinase plasminogen activator in hepatocellular carcinoma: A protocol for systematic review and meta analysis
por: Tao, Pengxian, et al.
Publicado: (2020)

Clinical significance of down-regulated HINT2 in hepatocellular carcinoma
por: Zhou, Dong-Kai, et al.
Publicado: (2019)

Oxeiptosis core genes and their multi-omics analysis in hepatocellular carcinoma
por: Lin, Sen, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_73b07aimp770e91v4nf7acgh29